Kim, J., Kim, T. E., Kim, J., Yun, J., Sohn, S., Shim, S. R., . . . Kim, S. J. (2014). Intravitreal Tanibirumab, a Fully Human Monoclonal Antibody Against Vascular Endothelial Growth Factor Receptor 2, Partially Suppresses and Regresses Laser-Induced Choroidal Neovascularization in a Rat Model. J Ocul Pharmacol Ther.
Stile di citazione ChicagoKim, Jaeryung, Tae Eun Kim, Ju-A Kim, Ji-Hyun Yun, Seongsoo Sohn, Sang Ryeol Shim, Sang Hoon Lee, e Sang Jin Kim. "Intravitreal Tanibirumab, a Fully Human Monoclonal Antibody Against Vascular Endothelial Growth Factor Receptor 2, Partially Suppresses and Regresses Laser-Induced Choroidal Neovascularization in a Rat Model." J Ocul Pharmacol Ther 2014.
Citazione MLAKim, Jaeryung, et al. "Intravitreal Tanibirumab, a Fully Human Monoclonal Antibody Against Vascular Endothelial Growth Factor Receptor 2, Partially Suppresses and Regresses Laser-Induced Choroidal Neovascularization in a Rat Model." J Ocul Pharmacol Ther 2014.